drugset / Trial / NCT06484634

Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss

NCT06484634

Completed 175 enrolled RESnTEC, Institute of Research
RandomizedParallel-groupOpen-labelTreatment

Summary

Using low-molecular-weight heparin (LMWH), outcomes such as live birth rate and the occurrence of pregnancy complications are some of the variables reported in some studies, with varying degrees of success. The present study aimed to compare the role of LMWH in unexplained recurrent pregnancy loss.

Timeline

Start
2023-12-01
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 40 mg Subcutaneous